Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Leukemia & Lymphoma|September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasmsXing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.Plos One|April 26, 2016
Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control StudyWei-Hsin Ting, Ming-Nan Chien, Fu-Sung Lo, et al.Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.International Journal of Endocrinology|March 10, 2020
Analysis of the Effect of Nine Consecutive Years' Intensive Management and Number of Times Achieving the Target Control on Endpoint Events in T2DM Patients in Sanlitun Community Health Service Center in BeijingChen-Mei Zhao, Xue-Li Cui, Gang Wan, et al.Cell Reports. Medicine|November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trialSi-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinomaSi-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.Lancet (London, England)|February 26, 2023
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialRui You, You-Ping Liu, Yu-Long Xie, et al.Respiratory Medicine|April 3, 2024
Benralizumab efficacy and safety in severe asthma: A randomized trial in AsiaKefang Lai, Dejun Sun, Ranran Dai, et al.Pageof 17